iSpecimen Inc. (ISPC) Tops Q2 EPS by 9c

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.86 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• JetBlue Vacations adds theme park experts for Orlando bookings
• Truist Securities Reiterates Hold Rating on Dollar General (DG)